Form 4: ResMed Counsel Acquires 2,941 Shares

ResMed's Global General Counsel, Michael J. Rider, acquired 2,941 shares of common stock through the vesting of performance-based restricted stock units.

Summary

• Michael J. Rider, ResMed Inc.'s Global General Counsel, acquired 2,941 shares of ResMed Common Stock.
• The acquisition occurred on August 15, 2025, at a price of $0 per share.
• These shares represent performance-based restricted stock units (RSUs) that were granted on November 20, 2024.
• The shares were earned because the compensation committee certified that the associated performance metrics were met.
• Following this transaction, Michael J. Rider beneficially owns 11,427 shares of ResMed Common Stock.
• The stock units are structured to vest 1/3 each year on the anniversary of the grant date.

Sentiment

Score: 7

Explanation: The acquisition of shares by a key executive through the vesting of performance-based restricted stock units indicates that performance metrics were met, aligning management interests with shareholders.

Positives

• A key executive, Michael J. Rider, increased his direct beneficial ownership in the company, aligning his interests with shareholders.
• The acquisition resulted from the vesting of performance-based restricted stock units, indicating that specific company performance metrics were successfully met.

Future Outlook

The remaining performance-based restricted stock units are scheduled to vest 1/3 each year on the anniversary of the grant date.

Industry Context

This filing details a routine executive compensation event, specifically the vesting of performance-based equity, which is a common practice across various industries to incentivize and retain key personnel.

Stakeholder Impact

• Shareholders: Increased alignment of management's interests with shareholder value due to increased executive stock ownership.
• Employees: Demonstrates the company's commitment to performance-based compensation, potentially boosting morale and incentivizing high performance.

Next Steps

• Future vesting of the remaining portions of the performance-based restricted stock units on subsequent anniversaries of the grant date.

Key Dates

Recommendation

The acquisition of shares by a key executive through the vesting of performance-based restricted stock units is a positive signal, indicating that performance metrics were met and aligning management interests with shareholders. However, a single insider transaction, even positive, typically warrants a 'hold' recommendation for a seasoned investor, pending broader financial and strategic analysis.

Keywords

ResMed, RMD, SEC Form 4, Insider Transaction, Stock Acquisition, Restricted Stock Units, RSU, Executive Compensation, Corporate Governance